Drug Type Small molecule drug |
Synonyms UCB 9260, UCB9260 |
Target |
Mechanism TNF inhibitors(Tumor necrosis factor inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H25N5O |
InChIKeyRZGFWGNCSYUEPR-UHFFFAOYSA-N |
CAS Registry1515888-53-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Preclinical | US | 19 Dec 2019 | |
Crohn Disease | Preclinical | GB | 19 Dec 2019 | |
Rheumatoid Arthritis | Preclinical | US | 19 Dec 2019 | |
Rheumatoid Arthritis | Preclinical | GB | 19 Dec 2019 |